Trial Profile
Long-Term Prospective Observational Study of the Risk of Cancer Among Pantoprazole Users.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2014
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary) ; Proton pump inhibitors
- Indications Oesophagitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2011 New trial record